7-day free trial: Get unlimited comparisons, and stock, ETF and mutual fund analyses for just $15/month, without ads. Start a trial. Go ad free!
BBH vs XLV
Both BBH and XLV are ETFs. BBH has a lower 5-year return than XLV (9.1% vs 13.49%). BBH has a higher expense ratio than XLV (0.35% vs 0.13%). Below is the comparison between BBH and XLV.
| BBH | XLV | |
|---|---|---|
| Segment | Equity: Global Biotech | Equity: U.S. Health Care |
| Issuer | VanEck | State Street Global Advisors |
| Net Assets | $478.8M | $25.69B |
| Expense Ratio | 0.35% | 0.13% |
| Management Style | passive (index-based) | passive (index-based) |
| Dividend Yield | 0.36% | 1.49% |
| Underlying Index | MVIS US Listed Biotech 25 Index | S&P Health Care Select Sector Index |
| YTD Return | 3.49% | 3.48% |
| 1-Year Return | 25.76% | 16.75% |
| 3-Year Return | 11.90% | 13.48% |
| 5-Year Return | 9.10% | 13.49% |
| 10-Year Return | N/A | 15.85% |
BBH description
The Fund seeks to replicate the price and yield performance of the Market Vectors US Listed Biotech 25 Index. The Index is comprised of common stocks and depository receipts of US exchange-listed companies in biotechnology sector.
BBH performance & returns
| YTD Return | 3.49% |
| 1-Month Return | 1.50% |
| 3-Month Return | 6.05% |
| 1-Year Return | 25.76% |
| 3-Year Return | 11.90% |
| 5-Year Return | 9.10% |
| 10-Year Return | N/A |
BBH expense ratio is 0.35%.
BBH holdings
Top 10 Holdings (61.45% of Total Assets)
| Name | Symbol | % Assets |
|---|---|---|
| Amgen Inc | AMGN | 14.27% |
| Gilead Sciences Inc | GILD | 7.23% |
| Moderna Inc | MRNA | 5.48% |
| Regeneron Pharmaceuticals Inc | REGN | 5.47% |
| Exact Sciences Corp | EXAS | 5.28% |
| Alexion Pharmaceuticals Inc | ALXN | 4.92% |
| IQVIA Holdings Inc | IQV | 4.91% |
| Biogen Inc | BIIB | 4.75% |
| Vertex Pharmaceuticals Inc | VRTX | 4.59% |
| Illumina Inc | ILMN | 4.55% |
Other relevant BBH comparisons
You may also want to check out the following BBH comparisons that investors often look for on Finny
Or use Finny Compare Wizard to create a comparison you’d like to see.
XLV description
The Fund seeks to provide investment results that, before expenses, correspond generally to the price and yield performance of the Health Care Select Sector Index. Under normal market conditions, the fund generally invests substantially all, but at least 95%, of its total assets in the securities comprising the Index.
XLV performance & returns
| YTD Return | 3.48% |
| 1-Month Return | 4.60% |
| 3-Month Return | 9.77% |
| 1-Year Return | 16.75% |
| 3-Year Return | 13.48% |
| 5-Year Return | 13.49% |
| 10-Year Return | 15.85% |
XLV expense ratio is 0.13%.
XLV holdings
Top 10 Holdings (51.66% of Total Assets)
| Name | Symbol | % Assets |
|---|---|---|
| Johnson & Johnson | JNJ | 9.45% |
| UnitedHealth Group Inc | UNH | 7.59% |
| Pfizer Inc | PFE | 5.16% |
| Merck & Co Inc | MRK | 4.98% |
| Thermo Fisher Scientific Inc | TMO | 4.90% |
| Abbott Laboratories | ABT | 4.87% |
| AbbVie Inc | ABBV | 3.93% |
| Danaher Corp | DHR | 3.79% |
| Medtronic PLC | MDT | 3.54% |
| Bristol-Myers Squibb Company | BMY | 3.45% |
Other relevant XLV comparisons
You may also want to check out the following XLV comparisons that investors often look for on Finny
- XLV vs FSKAX
- XLV vs ARKG
- XLV vs FSPHX
- XLV vs VOO
- XLV vs IBB
- XLV vs FXH
- XLV vs IXJ
- XLV vs IYH
- XLV vs FHLC
- XLV vs XBI
Or use Finny Compare Wizard to create a comparison you’d like to see.
You can check out all comparisons Finny users have looked for here. Feel free to the browse the list and view the comparisons that are of an interest to you.
